{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:49:43Z","timestamp":1791600583517,"version":"4.3.4"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"DOI":"10.1007\/s40120-026-01050-7","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:18:26Z","timestamp":1791551906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Migraine and Obesity: From Shared Mechanisms to Therapeutic Strategies"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9074-2803","authenticated-orcid":false,"given":"Marta","family":"Waliszewska-Pros\u00f3\u0142","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-1494","authenticated-orcid":false,"given":"Bianca","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-5039","authenticated-orcid":false,"given":"Lanfranco","family":"Pellesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-7779","authenticated-orcid":false,"given":"Alberto","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-6135","authenticated-orcid":false,"given":"Dilara","family":"Onan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-180X","authenticated-orcid":false,"given":"Karol","family":"Marschollek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-2045","authenticated-orcid":false,"given":"Danilo Antonio","family":"Montisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-7866","authenticated-orcid":false,"given":"Claudio","family":"Tana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-4128","authenticated-orcid":false,"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"1","key":"1050_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01889-x","volume":"25","author":"A Raggi","year":"2024","unstructured":"Raggi A, Leonardi M, Arruda M, et al. Hallmarks of primary headache: part 1 - migraine. J Headache Pain. 2024;25(1):189. https:\/\/doi.org\/10.1186\/s10194-024-01889-x.","journal-title":"J Headache Pain"},{"issue":"12","key":"1050_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S1474-4422(25)00402-8","volume":"24","author":"GBD 2023 Headache Collaborators","year":"2025","unstructured":"GBD 2023 Headache Collaborators. Global, regional, and national burden of headache disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurol. 2025;24(12):1005\u201315. https:\/\/doi.org\/10.1016\/S1474-4422(25)00402-8.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1050_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02142-9","volume":"26","author":"AK Hus\u00f8y","year":"2025","unstructured":"Hus\u00f8y AK, Yu S, Liu R, et al. The global prevalence of headache disorders of public-health importance: a meta-analysis of population-based individual participant data from 41,614 adults from 17 countries. J Headache Pain. 2025;26(1):204. https:\/\/doi.org\/10.1186\/s10194-025-02142-9.","journal-title":"J Headache Pain"},{"issue":"3","key":"1050_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092","volume":"50","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50(3):117\u201328. https:\/\/doi.org\/10.1097\/NT.0000000000000092.","journal-title":"Nutr Today"},{"issue":"10","key":"1050_CR5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.3390\/nu15102254","volume":"15","author":"GA Bray","year":"2023","unstructured":"Bray GA. Beyond BMI. Nutrients. 2023;15(10):2254. https:\/\/doi.org\/10.3390\/nu15102254.","journal-title":"Nutrients"},{"issue":"6","key":"1050_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21060757","volume":"21","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li D, Vermund SH. Advantages and limitations of the body mass index (BMI) to assess adult obesity. Int J Environ Res Public Health. 2024;21(6):757. https:\/\/doi.org\/10.3390\/ijerph21060757.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"1050_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0884533608321700","volume":"23","author":"R Ness-Abramof","year":"2008","unstructured":"Ness-Abramof R, Apovian CM. Waist circumference measurement in clinical practice. Nutr Clin Pract. 2008;23(4):397\u2013404. https:\/\/doi.org\/10.1177\/0884533608321700.","journal-title":"Nutr Clin Pract"},{"issue":"10481","key":"1050_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","volume":"405","author":"GBD 2021 Adult BMI Collaborators","year":"2025","unstructured":"GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405(10481):813\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(25)00355-1.","journal-title":"Lancet"},{"issue":"7","key":"1050_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10654-020-00650-3","volume":"35","author":"MCS Wong","year":"2020","unstructured":"Wong MCS, Huang J, Wang J, et al. Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2\u00a0million subjects. Eur J Epidemiol. 2020;35(7):673\u201383. https:\/\/doi.org\/10.1007\/s10654-020-00650-3.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1050_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01281-z","volume":"22","author":"V Caponnetto","year":"2021","unstructured":"Caponnetto V, Deodato M, Robotti M, et al. Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain. 2021;22(1):71. https:\/\/doi.org\/10.1186\/s10194-021-01281-z.","journal-title":"J Headache Pain"},{"issue":"19","key":"1050_CR11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/WNL.0000000000003919","volume":"88","author":"B Gelaye","year":"2017","unstructured":"Gelaye B, Sacco S, Brown WJ, Nitchie HL, Ornello R, Peterlin BL. Body composition status and the risk of migraine: a meta-analysis. Neurology. 2017;88(19):1795\u2013804. https:\/\/doi.org\/10.1212\/WNL.0000000000003919.","journal-title":"Neurology"},{"issue":"9","key":"1050_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214252","volume":"105","author":"SI Jang","year":"2025","unstructured":"Jang SI, Kim N, Han K, Lee MJ. Association between obesity and the risk of migraine: a nationwide cohort study in South Korea. Neurology. 2025;105(9):e214252. https:\/\/doi.org\/10.1212\/WNL.0000000000214252.","journal-title":"Neurology"},{"key":"1050_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1212\/01.wnl.0000225052.35019.f9","volume":"67","author":"ME Bigal","year":"2006","unstructured":"Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67:252\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000225052.35019.f9.","journal-title":"Neurology"},{"key":"1050_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-40","volume":"14","author":"SH Schramm","year":"2013","unstructured":"Schramm SH, Obermann M, Katsarava Z, Diener HC, Moebus S, Yoon MS. Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. J Headache Pain. 2013;14:40. https:\/\/doi.org\/10.1186\/1129-2377-14-40.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0993-0","volume":"20","author":"M Leonardi","year":"2019","unstructured":"Leonardi M, Raggi A. A narrative review on the burden of migraine: when the burden is the impact on people\u2019s life. J Headache Pain. 2019;20(1):41. https:\/\/doi.org\/10.1186\/s10194-019-0993-0.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01735-0","volume":"25","author":"M Waliszewska-Pros\u00f3\u0142","year":"2024","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Montisano DA, Antolak M, et al. The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study. J Headache Pain. 2024;25(1):27. https:\/\/doi.org\/10.1186\/s10194-024-01735-0.","journal-title":"J Headache Pain"},{"key":"1050_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2023.105320","volume":"119","author":"A Fayosse","year":"2024","unstructured":"Fayosse A, Dumurgier J, Dugravot A, Landr\u00e9 B, Singh-Manoux A, Sabia S. Cross-sectional and longitudinal associations of obesity with disability between age 50 and 90 in the SHARE study. Arch Gerontol Geriatr. 2024;119:105320. https:\/\/doi.org\/10.1016\/j.archger.2023.105320.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"1050_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-025-05895-9","volume":"25","author":"RA Fielding","year":"2025","unstructured":"Fielding RA, Rolland Y, Bruyere O, et al. Characterizing sarcopenia and sarcopenic obesity in patients aged 65\u00a0years and over, at risk of mobility disability: a multicenter observational trial (SARA-OBS). BMC Geriatr. 2025;25(1):590. https:\/\/doi.org\/10.1186\/s12877-025-05895-9.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1050_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-025-05897-7","volume":"25","author":"S Cavdar","year":"2025","unstructured":"Cavdar S, Kayhan Kocak FO, Savas S. Probable and confirmed sarcopenia are still better predictors of disability than sarcopenic obesity following ESPEN\/EASO consensus steps. BMC Geriatr. 2025;25(1):250. https:\/\/doi.org\/10.1186\/s12877-025-05897-7.","journal-title":"BMC Geriatr"},{"key":"1050_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.annepidem.2020.03.004","volume":"45","author":"Y Le Strat","year":"2020","unstructured":"Le Strat Y, Melchior M, Gorwood P, Tebeka S, Dubertret C. The role of comorbidity in the association of obesity with unemployment and disability. Ann Epidemiol. 2020;45:61\u20138. https:\/\/doi.org\/10.1016\/j.annepidem.2020.03.004.","journal-title":"Ann Epidemiol"},{"issue":"2","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JOM.0000000000001761","volume":"62","author":"A Ramasamy","year":"2020","unstructured":"Ramasamy A, Lalibert\u00e9 F, Aktavoukian SA, et al. Direct, absenteeism, and disability cost burden of obesity among privately insured employees: a comparison of healthcare industry versus other major industries in the United States. J Occup Environ Med. 2020;62(2):98\u2013107. https:\/\/doi.org\/10.1097\/JOM.0000000000001761.","journal-title":"J Occup Environ Med"},{"key":"1050_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/420858","volume":"2014","author":"A Verrotti","year":"2014","unstructured":"Verrotti A, Di Fonzo A, Penta L, Agostinelli S, Parisi P. Obesity and headache\/migraine: the importance of weight reduction through lifestyle modifications. Biomed Res Int. 2014;2014:420858. https:\/\/doi.org\/10.1155\/2014\/420858.","journal-title":"Biomed Res Int"},{"issue":"6","key":"1050_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1526-4610.2007.00810.x","volume":"47","author":"GE Tietjen","year":"2007","unstructured":"Tietjen GE, Peterlin BL, Brandes JL, et al. Depression and anxiety: effect on the migraine-obesity relationship. Headache. 2007;47(6):866\u201375. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00810.x.","journal-title":"Headache"},{"issue":"1","key":"1050_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01337-0","volume":"22","author":"CSJ Westgate","year":"2021","unstructured":"Westgate CSJ, Israelsen IME, Jensen RH, Eftekhari S. Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):123. https:\/\/doi.org\/10.1186\/s10194-021-01337-0.","journal-title":"J Headache Pain"},{"issue":"5","key":"1050_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/0333102417720213","volume":"38","author":"C Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez C, Vieites-Prado A, P\u00e9rez-Mato M, et al. Role of adipocytokines in the pathophysiology of migraine: a cross-sectional study. Cephalalgia. 2018;38(5):904\u201311. https:\/\/doi.org\/10.1177\/0333102417720213.","journal-title":"Cephalalgia"},{"issue":"4","key":"1050_CR26","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/head.12788","volume":"56","author":"BL Peterlin","year":"2016","unstructured":"Peterlin BL, Sacco S, Bernecker C, Scher AI. Adipokines and migraine: a systematic review. Headache. 2016;56(4):622\u201344. https:\/\/doi.org\/10.1111\/head.12788.","journal-title":"Headache"},{"issue":"4","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40120-025-00785-z","volume":"14","author":"C Tana","year":"2025","unstructured":"Tana C, Onan D, Messina R, et al. From headache to heart health: investigating the migraine-cardiovascular disease connection. Neurol Ther. 2025;14(4):1229\u201368. https:\/\/doi.org\/10.1007\/s40120-025-00785-z.","journal-title":"Neurol Ther"},{"issue":"14","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1177\/03331024221118924","volume":"42","author":"J Thuraiaiyah","year":"2022","unstructured":"Thuraiaiyah J, Erritz\u00f8e-Jervild M, Al-Khazali HM, Schytz HW, Younis S. The role of cytokines in migraine: a systematic review. Cephalalgia. 2022;42(14):1565\u201388. https:\/\/doi.org\/10.1177\/03331024221118924.","journal-title":"Cephalalgia"},{"key":"1050_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106072","volume":"180","author":"L Biscetti","year":"2023","unstructured":"Biscetti L, Cresta E, Cupini LM, Calabresi P, Sarchielli P. The putative role of neuroinflammation in the complex pathophysiology of migraine: from bench to bedside. Neurobiol Dis. 2023;180:106072. https:\/\/doi.org\/10.1016\/j.nbd.2023.106072.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1050_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","volume":"15","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine? Nat Rev Neurol. 2019;15(8):483\u201390. https:\/\/doi.org\/10.1038\/s41582-019-0216-y.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"1050_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/0333102416654883","volume":"37","author":"B Marics","year":"2017","unstructured":"Marics B, Peitl B, Varga A, et al. Diet-induced obesity alters dural CGRP release and potentiates TRPA1-mediated trigeminovascular responses. Cephalalgia. 2017;37(6):581\u201391. https:\/\/doi.org\/10.1177\/0333102416654883.","journal-title":"Cephalalgia"},{"issue":"1","key":"1050_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04319-w","volume":"25","author":"C Uluta\u015f","year":"2025","unstructured":"Uluta\u015f C, Bay\u0131r BRH, \u00c7etinkaya Y, G\u00fcler EM, A\u011f\u0131rcan D, \u00d6zkan BN. Migraine and neuroinflammation: correlation of adipokines and cytokines with clinical features. BMC Neurol. 2025;25(1):338. https:\/\/doi.org\/10.1186\/s12883-025-04319-w.","journal-title":"BMC Neurol"},{"issue":"8","key":"1050_CR33","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1177\/0333102418807182","volume":"39","author":"M Abbasi","year":"2019","unstructured":"Abbasi M, Noori-Zadeh A, Seidkhani-Nahal A, Kaffashian M, Bakhtiyari S, Panahi S. Leptin, adiponectin, and resistin blood adipokine levels in migraineurs: systematic reviews and meta-analyses. Cephalalgia. 2019;39(8):1010\u201321. https:\/\/doi.org\/10.1177\/0333102418807182.","journal-title":"Cephalalgia"},{"issue":"24","key":"1050_CR34","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1212\/WNL.0000000000001067","volume":"83","author":"JL Dearborn","year":"2014","unstructured":"Dearborn JL, Schneider AL, Gottesman RF, et al. Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study. Neurology. 2014;83(24):2211\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000001067.","journal-title":"Neurology"},{"issue":"6","key":"1050_CR35","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s11695-020-04429-z","volume":"30","author":"A Di Vincenzo","year":"2020","unstructured":"Di Vincenzo A, Beghetto M, Vettor R, et al. Effects of surgical and non-surgical weight loss on migraine headache: a systematic review and meta-analysis. Obes Surg. 2020;30(6):2173\u201385.","journal-title":"Obes Surg"},{"issue":"8","key":"1050_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA. Migraine and the trigeminovascular system-40\u00a0years and counting. Lancet Neurol. 2019;18(8):795\u2013804. https:\/\/doi.org\/10.1016\/S1474-4422(19)30185-1.","journal-title":"Lancet Neurol"},{"issue":"19","key":"1050_CR37","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M. Migraine. N Engl J Med. 2020;383(19):1866\u201376. https:\/\/doi.org\/10.1056\/NEJMra1915327.","journal-title":"N Engl J Med"},{"issue":"11","key":"1050_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/17512433.2024.2417655","volume":"17","author":"M Waliszewska-Pros\u00f3\u0142","year":"2024","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Raffaelli B, Straburzy\u0144ski M, Martelletti P. Understanding the efficacy and tolerability of migraine treatment: a deep dive into CGRP antagonists. Expert Rev Clin Pharmacol. 2024;17(11):1039\u201351. https:\/\/doi.org\/10.1080\/17512433.2024.2417655.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"1050_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/joim.13506","volume":"292","author":"L Edvinsson","year":"2022","unstructured":"Edvinsson L. Calcitonin gene-related peptide (CGRP) is a key molecule released in acute migraine attacks-successful translation of basic science to clinical practice. J Intern Med. 2022;292(4):575\u201386. https:\/\/doi.org\/10.1111\/joim.13506.","journal-title":"J Intern Med"},{"issue":"5","key":"1050_CR40","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1210\/en.2016-1510","volume":"158","author":"T Liu","year":"2017","unstructured":"Liu T, Kamiyoshi A, Sakurai T, et al. Endogenous calcitonin gene-related peptide regulates lipid metabolism and energy homeostasis in male mice. Endocrinology. 2017;158(5):1194\u2013206. https:\/\/doi.org\/10.1210\/en.2016-1510.","journal-title":"Endocrinology"},{"issue":"9","key":"1050_CR41","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1210\/en.2010-0284","volume":"151","author":"CS Walker","year":"2010","unstructured":"Walker CS, Li X, Whiting L, et al. Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity. Endocrinology. 2010;151(9):4257\u201369. https:\/\/doi.org\/10.1210\/en.2010-0284.","journal-title":"Endocrinology"},{"issue":"16","key":"1050_CR42","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer M. The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment. J Am Coll Cardiol. 2025;86(16):1269\u2013373. https:\/\/doi.org\/10.1016\/j.jacc.2025.06.055.","journal-title":"J Am Coll Cardiol"},{"key":"1050_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejphar.2016.01.003","volume":"773","author":"C Nilsson","year":"2016","unstructured":"Nilsson C, Hansen TK, Rosenquist C, et al. Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1. Eur J Pharmacol. 2016;773:24\u201331. https:\/\/doi.org\/10.1016\/j.ejphar.2016.01.003.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"1050_CR44","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214945","volume":"106","author":"E Caronna","year":"2026","unstructured":"Caronna E, Mas-de-Les-Valls R, Egeo G, et al. Long-term effectiveness and persistence factors of anti-CGRP monoclonal antibodies in migraine: 2-year results from the EUREkA cohort. Neurology. 2026;106(12):e214945. https:\/\/doi.org\/10.1212\/WNL.0000000000214945.","journal-title":"Neurology"},{"issue":"3","key":"1050_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00409-9","volume":"21","author":"L Al-Hassany","year":"2022","unstructured":"Al-Hassany L, Goadsby PJ, Danser AHJ, MaassenVanDenBrink A. Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions. Lancet Neurol. 2022;21(3):284\u201394. https:\/\/doi.org\/10.1016\/S1474-4422(21)00409-9.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1050_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/14737175.2024.2328728","volume":"24","author":"EC Stanyer","year":"2024","unstructured":"Stanyer EC, Hoffmann J, Holland PR. Orexins and primary headaches: an overview of the neurobiology and clinical impact. Expert Rev Neurother. 2024;24(5):487\u201396. https:\/\/doi.org\/10.1080\/14737175.2024.2328728.","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"1050_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13311-017-0602-3","volume":"15","author":"LC Strother","year":"2018","unstructured":"Strother LC, Srikiatkhachorn A, Supronsinchai W. Targeted orexin and hypothalamic neuropeptides for migraine. Neurotherapeutics. 2018;15(2):377\u201390. https:\/\/doi.org\/10.1007\/s13311-017-0602-3.","journal-title":"Neurotherapeutics"},{"issue":"28","key":"1050_CR48","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.2174\/138161210793292483","volume":"16","author":"LC Chiou","year":"2010","unstructured":"Chiou LC, Lee HJ, Ho YC, et al. Orexins\/hypocretins: pain regulation and cellular actions. Curr Pharm Des. 2010;16(28):3089\u2013100. https:\/\/doi.org\/10.2174\/138161210793292483.","journal-title":"Curr Pharm Des"},{"key":"1050_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nbd.2014.10.022","volume":"74","author":"J Hoffmann","year":"2015","unstructured":"Hoffmann J, Supronsinchai W, Akerman S, et al. Evidence for orexinergic mechanisms in migraine. Neurobiol Dis. 2015;74:137\u201343. https:\/\/doi.org\/10.1016\/j.nbd.2014.10.022.","journal-title":"Neurobiol Dis"},{"key":"1050_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/7854_2016_51","volume":"33","author":"PB Goforth","year":"2017","unstructured":"Goforth PB, Myers MG. Roles for orexin\/hypocretin in the control of energy balance and metabolism. Curr Top Behav Neurosci. 2017;33:137\u201356. https:\/\/doi.org\/10.1007\/7854_2016_51.","journal-title":"Curr Top Behav Neurosci"},{"issue":"5","key":"1050_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/0333102414544979","volume":"35","author":"A Chabi","year":"2015","unstructured":"Chabi A, Zhang Y, Jackson S, et al. Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis. Cephalalgia. 2015;35(5):379\u201388. https:\/\/doi.org\/10.1177\/0333102414544979.","journal-title":"Cephalalgia"},{"issue":"1","key":"1050_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02044-w","volume":"26","author":"AB Salinas-Abarca","year":"2025","unstructured":"Salinas-Abarca AB, Gamal-Eltrabily M, Romero-Reyes M, Akerman S. The role and interaction of hypothalamic-related neurotransmitters in migraine. J Headache Pain. 2025;26(1):110. https:\/\/doi.org\/10.1186\/s10194-025-02044-w.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02233-7","volume":"27","author":"A Raggi","year":"2025","unstructured":"Raggi A, Castaldo M, Chiang CC, et al. Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease Study. J Headache Pain. 2025;27(1):9. https:\/\/doi.org\/10.1186\/s10194-025-02233-7.","journal-title":"J Headache Pain"},{"issue":"4","key":"1050_CR54","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S1474-4422(08)70062-0","volume":"7","author":"R Jensen","year":"2008","unstructured":"Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008;7(4):354\u201361. https:\/\/doi.org\/10.1016\/S1474-4422(08)70062-0.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1050_CR55","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1111\/ejn.16087","volume":"58","author":"EL Beech","year":"2023","unstructured":"Beech EL, Riddell N, Murphy MJ, Crewther SG. Sex and stress hormone dysregulation as clinical manifestations of hypothalamic function in migraine disorder: a meta-analysis. Eur J Neurosci. 2023;58(4):3150\u201371. https:\/\/doi.org\/10.1111\/ejn.16087.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"1050_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02126-9","volume":"26","author":"U Pensato","year":"2025","unstructured":"Pensato U, Ornello R, Rosignoli C, et al. Longitudinal assessment of migraine burden in resistant and refractory migraine - data from the prospective REFINE study. J Headache Pain. 2025;26(1):184. https:\/\/doi.org\/10.1186\/s10194-025-02126-9.","journal-title":"J Headache Pain"},{"key":"1050_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2023.101889","volume":"73","author":"B B\u0142aszczyk","year":"2024","unstructured":"B\u0142aszczyk B, Martynowicz H, Wi\u0119ckiewicz M, et al. Prevalence of headaches and their relationship with obstructive sleep apnea (OSA) - systematic review and meta-analysis. Sleep Med Rev. 2024;73:101889. https:\/\/doi.org\/10.1016\/j.smrv.2023.101889.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"1050_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-026-02425-9","volume":"27","author":"K Marschollek","year":"2026","unstructured":"Marschollek K, Martynowicz H, Budrewicz S, Straburzy\u0144ski M, Waliszewska-Pros\u00f3\u0142 M. Sleep quality and chronotype in primary headache disorders: a nationwide population-based study of 5,311 Polish adults. J Headache Pain. 2026;27(1):160. https:\/\/doi.org\/10.1186\/s10194-026-02425-9.","journal-title":"J Headache Pain"},{"issue":"7","key":"1050_CR59","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/head.13358","volume":"58","author":"A Vgontzas","year":"2018","unstructured":"Vgontzas A, Pavlovi\u0107 JM. Sleep disorders and migraine: review of literature and potential pathophysiology mechanisms. Headache. 2018;58(7):1030\u20139. https:\/\/doi.org\/10.1111\/head.13358.","journal-title":"Headache"},{"issue":"4","key":"1050_CR60","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/head.14904","volume":"65","author":"TY Chen","year":"2025","unstructured":"Chen TY, Hsieh TY, Wang YH, Chang R, Hung YM, Wei JC. Association between obstructive sleep apnea and migraine: a United States population-based cohort study. Headache. 2025;65(4):608\u201318. https:\/\/doi.org\/10.1111\/head.14904.","journal-title":"Headache"},{"issue":"1","key":"1050_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/head.13435","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Rains JC, Pavlovic JM, et al. Sleep disorders among people with migraine: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache. 2019;59(1):32\u201345. https:\/\/doi.org\/10.1111\/head.13435.","journal-title":"Headache"},{"issue":"9","key":"1050_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fendo.2018.00431","volume":"31","author":"SRS Ouakinin","year":"2018","unstructured":"Ouakinin SRS, Barreira DP, Gois CJ. Depression and obesity: integrating the role of stress, neuroendocrine dysfunction and inflammatory pathways. Front Endocrinol (Lausanne). 2018;31(9):431. https:\/\/doi.org\/10.3389\/fendo.2018.00431.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1050_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-1078-9","volume":"21","author":"M Arzani","year":"2020","unstructured":"Arzani M, Jahromi SR, Ghorbani Z, et al. Gut-brain axis and migraine headache: a comprehensive review. J Headache Pain. 2020;21(1):15. https:\/\/doi.org\/10.1186\/s10194-020-1078-9.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01821-3","volume":"25","author":"W Halloum","year":"2024","unstructured":"Halloum W, Dughem YA, Beier D, Pellesi L. Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review. J Headache Pain. 2024;25(1):112. https:\/\/doi.org\/10.1186\/s10194-024-01821-3.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR65","doi-asserted-by":"publisher","DOI":"10.1172\/JCI196346","volume":"136","author":"ZS Lorsch","year":"2026","unstructured":"Lorsch ZS, Liddle RA. Mechanisms and clinical implications of gut-brain interactions. J Clin Investig. 2026;136(1):e196346. https:\/\/doi.org\/10.1172\/JCI196346.","journal-title":"J Clin Investig"},{"issue":"1","key":"1050_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0306-4522(96)00434-4","volume":"77","author":"PJ Larsen","year":"1997","unstructured":"Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience. 1997;77(1):257\u201370. https:\/\/doi.org\/10.1016\/s0306-4522(96)00434-4.","journal-title":"Neuroscience"},{"issue":"1","key":"1050_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01302-x","volume":"22","author":"F Jing","year":"2021","unstructured":"Jing F, Zou Q, Wang Y, Cai Z, Tang Y. Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation. J Headache Pain. 2021;22(1):86. https:\/\/doi.org\/10.1186\/s10194-021-01302-x.","journal-title":"J Headache Pain"},{"key":"1050_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2023.137397","volume":"812","author":"F Jing","year":"2023","unstructured":"Jing F, Zou Q, Pu Y. GLP-1R agonist liraglutide attenuates pain hypersensitivity by stimulating IL-10 release in a nitroglycerin-induced chronic migraine mouse model. Neurosci Lett. 2023;812:137397. https:\/\/doi.org\/10.1016\/j.neulet.2023.137397.","journal-title":"Neurosci Lett"},{"issue":"15","key":"1050_CR69","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1523\/JNEUROSCI.4703-13.2014","volume":"34","author":"N Gong","year":"2014","unstructured":"Gong N, Xiao Q, Zhu B, et al. Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity. J Neurosci. 2014;34(15):5322\u201334. https:\/\/doi.org\/10.1523\/JNEUROSCI.4703-13.2014.","journal-title":"J Neurosci"},{"key":"1050_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nbd.2017.01.005","volume":"101","author":"M Martins-Oliveira","year":"2017","unstructured":"Martins-Oliveira M, Akerman S, Holland PR, Hoffmann JR, Tavares I, Goadsby PJ. Neuroendocrine signaling modulates specific neural networks relevant to migraine. Neurobiol Dis. 2017;101:16\u201326. https:\/\/doi.org\/10.1016\/j.nbd.2017.01.005.","journal-title":"Neurobiol Dis"},{"issue":"11","key":"1050_CR71","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1177\/0333102410364674","volume":"30","author":"C Bernecker","year":"2010","unstructured":"Bernecker C, Pailer S, Kieslinger P, et al. GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs. Cephalalgia. 2010;30(11):1366\u201374. https:\/\/doi.org\/10.1177\/0333102410364674.","journal-title":"Cephalalgia"},{"issue":"11","key":"1050_CR72","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1177\/0333102417748928","volume":"38","author":"ZO Siva","year":"2018","unstructured":"Siva ZO, Uluduz D, Keskin FE, et al. Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine. Cephalalgia. 2018;38(11):1773\u201381. https:\/\/doi.org\/10.1177\/0333102417748928.","journal-title":"Cephalalgia"},{"issue":"1","key":"1050_CR73","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s10194-025-02039-7","volume":"26","author":"CW Mugo","year":"2025","unstructured":"Mugo CW, Church E, Horniblow RD, et al. Unravelling the gut-brain connection: a systematic review of migraine and the gut microbiome. J Headache Pain. 2025;26(1):125. https:\/\/doi.org\/10.1186\/s10194-025-02039-7.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01163-w","volume":"21","author":"ES Kristoffersen","year":"2020","unstructured":"Kristoffersen ES, B\u00f8rte S, Hagen K, Zwart JA, Winsvold BS. Migraine, obesity and body fat distribution - a population-based study. J Headache Pain. 2020;21(1):97. https:\/\/doi.org\/10.1186\/s10194-020-01163-w.","journal-title":"J Headache Pain"},{"key":"1050_CR75","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8219254","author":"P Ojha","year":"2022","unstructured":"Ojha P, Malhotra V. Implication of high body fat percentage on migraine chronification in premenopausal females. Neurol Res Int. 2022. https:\/\/doi.org\/10.1155\/2022\/8219254.","journal-title":"Neurol Res Int"},{"key":"1050_CR76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocn.2023.07.007","volume":"115","author":"TM Saffari","year":"2023","unstructured":"Saffari TM, Kavanagh K, Ormseth B, Palettas M, Janis JE. Severe obesity is associated with increased migraine severity and frequency: a retrospective cohort study. J Clin Neurosci. 2023;115:8\u201313. https:\/\/doi.org\/10.1016\/j.jocn.2023.07.007.","journal-title":"J Clin Neurosci"},{"issue":"1-2","key":"1050_CR77","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0304-3959(03)00293-8","volume":"106","author":"AI Scher","year":"2003","unstructured":"Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106(1\u20132):81\u20139. https:\/\/doi.org\/10.1016\/s0304-3959(03)00293-8.","journal-title":"Pain"},{"key":"1050_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-015-0510-z","volume":"16","author":"R Ornello","year":"2015","unstructured":"Ornello R, Ripa P, Pistoia F, et al. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies. J Headache Pain. 2015;16:27. https:\/\/doi.org\/10.1186\/s10194-015-0510-z.","journal-title":"J Headache Pain"},{"issue":"5","key":"1050_CR79","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/0333102419883355","volume":"40","author":"J Xu","year":"2020","unstructured":"Xu J, Kong F, Buse DC. Predictors of episodic migraine transformation to chronic migraine: a systematic review and meta-analysis of observational cohort studies. Cephalalgia. 2020;40(5):503\u201316. https:\/\/doi.org\/10.1177\/0333102419883355.","journal-title":"Cephalalgia"},{"key":"1050_CR80","unstructured":"Togha M, Haghdoost F, Khorsha F, Razeghi Jahromi S, Ghorbani Z. Body mass index and its association with migraine characteristics in female patients.\u00a0Arch Iran Med. 2019;22(10):554\u201359."},{"key":"1050_CR81","doi-asserted-by":"publisher","unstructured":"Fakher MK, Hassan ZN. The effect of body mass index on migraine severity in female patients. Thi-Qar Med J. 2023. https:\/\/doi.org\/10.32792\/tmj.v26i2.455.","DOI":"10.32792\/tmj.v26i2.455"},{"issue":"2","key":"1050_CR82","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1468-2982.2008.01716.x","volume":"29","author":"AC Winter","year":"2009","unstructured":"Winter AC, Berger K, Buring JE, Kurth T. Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia. 2009;29(2):269\u201378. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01716.x.","journal-title":"Cephalalgia"},{"issue":"3","key":"1050_CR83","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000316656","volume":"64","author":"JF T\u00e9llez-Zenteno","year":"2010","unstructured":"T\u00e9llez-Zenteno JF, Pahwa DR, Hernandez-Ronquillo L, Garc\u00eda-Ramos G, Vel\u00e1zquez A. Association between body mass index and migraine. Eur Neurol. 2010;64(3):134\u20139. https:\/\/doi.org\/10.1159\/000316656.","journal-title":"Eur Neurol"},{"issue":"7","key":"1050_CR84","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10194-012-0470-5","volume":"13","author":"S Yu","year":"2012","unstructured":"Yu S, Liu R, Yang X, et al. Body mass index and migraine: a survey of the Chinese adult population. J Headache Pain. 2012;13(7):531\u20136. https:\/\/doi.org\/10.1007\/s10194-012-0470-5.","journal-title":"J Headache Pain"},{"issue":"15","key":"1050_CR85","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/WNL.0b013e3182a824f7","volume":"81","author":"BL Peterlin","year":"2013","unstructured":"Peterlin BL, Rosso AL, Williams MA, et al. Episodic migraine and obesity and the influence of age, race, and sex. Neurology. 2013;81(15):1314\u201321. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a824f7.","journal-title":"Neurology"},{"issue":"1","key":"1050_CR86","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1526-4610.2009.01459.x","volume":"50","author":"BL Peterlin","year":"2010","unstructured":"Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache. 2010;50(1):52\u201362. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01459.x.","journal-title":"Headache"},{"issue":"4","key":"1050_CR87","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1526-4610.2010.01833.x","volume":"51","author":"M Vo","year":"2011","unstructured":"Vo M, Ainalem A, Qiu C, Peterlin BL, Aurora SK, Williams MA. Body mass index and adult weight gain among reproductive age women with migraine. Headache. 2011;51(4):559\u201369. https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01833.x.","journal-title":"Headache"},{"issue":"3","key":"1050_CR88","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40120-025-00720-2","volume":"14","author":"M Waliszewska-Pros\u00f3\u0142","year":"2025","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Grandi G, Ornello R, et al. Menopause, perimenopause, and migraine: understanding the intersections and implications for treatment. Neurol Ther. 2025;14(3):665\u201380. https:\/\/doi.org\/10.1007\/s40120-025-00720-2.","journal-title":"Neurol Ther"},{"issue":"1-2","key":"1050_CR89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000489663","volume":"51","author":"VA Andreeva","year":"2018","unstructured":"Andreeva VA, Fezeu LK, Hercberg S, Galan P. Obesity and migraine: effect modification by gender and perceived stress. Neuroepidemiology. 2018;51(1\u20132):25\u201332. https:\/\/doi.org\/10.1159\/000489663.","journal-title":"Neuroepidemiology"},{"issue":"6","key":"1050_CR90","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/head.12088","volume":"53","author":"S Ravid","year":"2013","unstructured":"Ravid S, Shahar E, Schiff A, Gordon S. Obesity in children with headaches: association with headache type, frequency, and disability. Headache. 2013;53(6):954\u201361. https:\/\/doi.org\/10.1111\/head.12088.","journal-title":"Headache"},{"key":"1050_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1225935","volume":"14","author":"C Quispe-Vicu\u00f1a","year":"2023","unstructured":"Quispe-Vicu\u00f1a C, Soriano-Moreno DR, De-Los-Rios-Pinto A, et al. Association between weight status and migraine in the paediatric population: a systematic review and meta-analysis. Front Neurol. 2023;14:1225935. https:\/\/doi.org\/10.3389\/fneur.2023.1225935.","journal-title":"Front Neurol"},{"key":"1050_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1072419","volume":"13","author":"XX Bu","year":"2023","unstructured":"Bu XX, Zhu LH, Wang ZM, Lu C, Chen H, Yu D. Association of obesity with headache among US children and adolescents: evidence from NHANES 1999-2004. Front Endocrinol (Lausanne). 2023;13:1072419. https:\/\/doi.org\/10.3389\/fendo.2022.1072419.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1050_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15050474","volume":"15","author":"C Cavestro","year":"2025","unstructured":"Cavestro C. Metabolic dysfunction and dietary interventions in migraine management: the role of insulin resistance and neuroinflammation-A narrative and scoping review. Brain Sci. 2025;15(5):474. https:\/\/doi.org\/10.3390\/brainsci15050474.","journal-title":"Brain Sci"},{"issue":"1","key":"1050_CR94","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/14737175.2023.2173575","volume":"23","author":"SR Jahromi","year":"2023","unstructured":"Jahromi SR, Martami F, Morad Soltani K, Togha M. Migraine and obesity: what is the real direction of their association? Expert Rev Neurother. 2023;23(1):75\u201384. https:\/\/doi.org\/10.1080\/14737175.2023.2173575.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"1050_CR95","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/oby.22069","volume":"26","author":"DS Bond","year":"2018","unstructured":"Bond DS, Thomas JG, Lipton RB, et al. Behavioral weight loss intervention for migraine: a randomized controlled trial. Obesity (Silver Spring). 2018;26(1):81\u20137. https:\/\/doi.org\/10.1002\/oby.22069.","journal-title":"Obesity (Silver Spring)"},{"key":"1050_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.719467","volume":"13","author":"M Agbetou","year":"2022","unstructured":"Agbetou M, Adoukonou T. Lifestyle modifications for migraine management. Front Neurol. 2022;13:719467. https:\/\/doi.org\/10.3389\/fneur.2022.719467.","journal-title":"Front Neurol"},{"issue":"1","key":"1050_CR97","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40795-025-01048-8","volume":"11","author":"SM Legesse","year":"2025","unstructured":"Legesse SM, Addila AE, Jena BH, Jikamo B, Abdissa ZD, Hailemarim T. Irregular meal and migraine headache: a scoping review. BMC Nutr. 2025;11(1):60. https:\/\/doi.org\/10.1186\/s40795-025-01048-8.","journal-title":"BMC Nutr"},{"issue":"8","key":"1050_CR98","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11916-021-00966-z","volume":"25","author":"KN Arca","year":"2021","unstructured":"Arca KN, Halker Singh RB. Dehydration and headache. Curr Pain Headache Rep. 2021;25(8):56. https:\/\/doi.org\/10.1007\/s11916-021-00966-z.","journal-title":"Curr Pain Headache Rep"},{"key":"1050_CR99","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0072-9752(10)97012-7","volume":"97","author":"C W\u00f6ber","year":"2010","unstructured":"W\u00f6ber C, W\u00f6ber-Bing\u00f6l C. Triggers of migraine and tension-type headache. Handb Clin Neurol. 2010;97:161\u201372. https:\/\/doi.org\/10.1016\/S0072-9752(10)97012-7.","journal-title":"Handb Clin Neurol"},{"key":"1050_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.618375","volume":"11","author":"U Raucci","year":"2021","unstructured":"Raucci U, Boni A, Evangelisti M, et al. Lifestyle modifications to help prevent headache at a developmental age. Front Neurol. 2021;11:618375. https:\/\/doi.org\/10.3389\/fneur.2020.618375.","journal-title":"Front Neurol"},{"issue":"1","key":"1050_CR101","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1515\/med-2022-0598","volume":"17","author":"F Haghdoost","year":"2022","unstructured":"Haghdoost F, Togha M. Migraine management: non-pharmacological points for patients and health care professionals. Open Med (Wars). 2022;17(1):1869\u201382. https:\/\/doi.org\/10.1515\/med-2022-0598.","journal-title":"Open Med (Wars)"},{"issue":"8","key":"1050_CR102","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.clnu.2024.06.015","volume":"43","author":"I Olivito","year":"2024","unstructured":"Olivito I, Simona F, Tarsitano A, et al. Mediterranean ketogenic diet accounts for reduced pain frequency and intensity in patients with chronic migraine: a pilot study. Clin Nutr. 2024;43(8):1781\u20137. https:\/\/doi.org\/10.1016\/j.clnu.2024.06.015.","journal-title":"Clin Nutr"},{"issue":"1","key":"1050_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1028415X.2021.2009162","volume":"26","author":"A Arab","year":"2023","unstructured":"Arab A, Khorvash F, Karimi E, Hadi A, Askari G. Associations between adherence to Mediterranean dietary pattern and frequency, duration, and severity of migraine headache: a cross-sectional study. Nutr Neurosci. 2023;26(1):1\u201310. https:\/\/doi.org\/10.1080\/1028415X.2021.2009162.","journal-title":"Nutr Neurosci"},{"issue":"1","key":"1050_CR104","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/ene.12550","volume":"22","author":"C Di Lorenzo","year":"2015","unstructured":"Di Lorenzo C, Coppola G, Sirianni G, et al. Migraine improvement during short lasting ketogenesis: a proof-of-concept study. Eur J Neurol. 2015;22(1):170\u20137. https:\/\/doi.org\/10.1111\/ene.12550.","journal-title":"Eur J Neurol"},{"issue":"6","key":"1050_CR105","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/nutrit\/nuab080","volume":"80","author":"MC Caminha","year":"2022","unstructured":"Caminha MC, Moreira AB, Matheus FC, et al. Efficacy and tolerability of the ketogenic diet and its variations for preventing migraine in adolescents and adults: a systematic review. Nutr Rev. 2022;80(6):1634\u201347. https:\/\/doi.org\/10.1093\/nutrit\/nuab080.","journal-title":"Nutr Rev"},{"issue":"20","key":"1050_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/nu15204334","volume":"15","author":"Y Tereshko","year":"2023","unstructured":"Tereshko Y, Dal Bello S, Di Lorenzo C, et al. The effect of three different ketogenic diet protocols on migraine and fatigue in chronic and high-frequency episodic migraine: a pilot study. Nutrients. 2023;15(20):4334. https:\/\/doi.org\/10.3390\/nu15204334.","journal-title":"Nutrients"},{"issue":"7","key":"1050_CR107","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/head.13836","volume":"60","author":"NA Hindiyeh","year":"2020","unstructured":"Hindiyeh NA, Zhang N, Farrar M, Banerjee P, Lombard L, Aurora SK. The role of diet and nutrition in migraine triggers and treatment: a systematic literature review. Headache. 2020;60(7):1300\u201316. https:\/\/doi.org\/10.1111\/head.13836.","journal-title":"Headache"},{"issue":"4","key":"1050_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/nu17040669","volume":"17","author":"YH Tu","year":"2025","unstructured":"Tu YH, Chang CM, Yang CC, Tsai IJ, Chou YC, Yang CP. Dietary patterns and migraine: insights and impact. Nutrients. 2025;17(4):669. https:\/\/doi.org\/10.3390\/nu17040669.","journal-title":"Nutrients"},{"issue":"3","key":"1050_CR109","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11916-020-00929-w","volume":"25","author":"TJ Song","year":"2021","unstructured":"Song TJ, Chu MK. Exercise in treatment of migraine including chronic migraine. Curr Pain Headache Rep. 2021;25(3):14. https:\/\/doi.org\/10.1007\/s11916-020-00929-w.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"1050_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0902-y","volume":"19","author":"FM Amin","year":"2018","unstructured":"Amin FM, Aristeidou S, Baraldi C, et al. The association between migraine and physical exercise. J Headache Pain. 2018;19(1):83. https:\/\/doi.org\/10.1186\/s10194-018-0902-y.","journal-title":"J Headache Pain"},{"issue":"6","key":"1050_CR111","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/sms.13625","volume":"30","author":"R La Touche","year":"2020","unstructured":"La Touche R, Fern\u00e1ndez P\u00e9rez JJ, Proy Acosta A, et al. Is aerobic exercise helpful in patients with migraine? A systematic review and meta-analysis. Scand J Med Sci Sports. 2020;30(6):965\u201382. https:\/\/doi.org\/10.1111\/sms.13625.","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"1050_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01503-y","volume":"23","author":"YW Woldeamanuel","year":"2022","unstructured":"Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain. 2022;23(1):134. https:\/\/doi.org\/10.1186\/s10194-022-01503-y.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04471-3","volume":"25","author":"D Onan","year":"2025","unstructured":"Onan D, Ar\u0131kan H, Vurall\u0131 D, et al. Fear of movement: validity and reliability study of the Turkish version of the Tampa scale of kinesiophobia for headache in patients with migraine. BMC Neurol. 2025;25(1):445. https:\/\/doi.org\/10.1186\/s12883-025-04471-3.","journal-title":"BMC Neurol"},{"issue":"11","key":"1050_CR114","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1177\/0333102417747231","volume":"38","author":"SG Farris","year":"2018","unstructured":"Farris SG, Thomas JG, Abrantes AM, et al. Pain worsening with physical activity during migraine attacks in women with overweight\/obesity: a prospective evaluation of frequency, consistency, and correlates. Cephalalgia. 2018;38(11):1707\u201315. https:\/\/doi.org\/10.1177\/0333102417747231.","journal-title":"Cephalalgia"},{"key":"1050_CR115","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2026.10081","volume":"15","author":"D Zhai","year":"2026","unstructured":"Zhai D, Zhang S, Gong Z, et al. Association between carbohydrate consumption and self-assessed severe headache or migraine among American adults. J Nutr Sci. 2026;15:e24. https:\/\/doi.org\/10.1017\/jns.2026.10081.","journal-title":"J Nutr Sci"},{"key":"1050_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1719724","volume":"16","author":"CA Nelson","year":"2026","unstructured":"Nelson CA, Reavely KW, Jennings MR, et al. Glucose dysregulation and glycemic phenotyping in chronic migraine. Front Neurol. 2026;16:1719724. https:\/\/doi.org\/10.3389\/fneur.2025.1719724.","journal-title":"Front Neurol"},{"key":"1050_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.852616","volume":"13","author":"T Klan","year":"2022","unstructured":"Klan T, Gaul C, Liesering-Latta E, et al. Efficacy of cognitive-behavioral therapy for the prophylaxis of migraine in adults: a three-armed randomized controlled trial. Front Neurol. 2022;13:852616. https:\/\/doi.org\/10.3389\/fneur.2022.852616.","journal-title":"Front Neurol"},{"key":"1050_CR118","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/PRBM.S113278","volume":"10","author":"G Castelnuovo","year":"2017","unstructured":"Castelnuovo G, Pietrabissa G, Manzoni GM, et al. Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives. Psychol Res Behav Manag. 2017;10:165\u201373. https:\/\/doi.org\/10.2147\/PRBM.S113278.","journal-title":"Psychol Res Behav Manag"},{"issue":"6","key":"1050_CR119","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/nu12061579","volume":"12","author":"C Altamura","year":"2020","unstructured":"Altamura C, Cecchi G, Bravo M, et al. What is needed for evidence-based dietary recommendations for migraine: a call to action for nutrition and microbiome research. Nutrients. 2020;12(6):1579. https:\/\/doi.org\/10.3390\/nu12061579.","journal-title":"Nutrients"},{"issue":"6","key":"1050_CR120","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.clinthera.2008.06.005","volume":"30","author":"FR Taylor","year":"2008","unstructured":"Taylor FR. Weight change associated with the use of migraine-preventive medications. Clin Ther. 2008;30(6):1069\u201380. https:\/\/doi.org\/10.1016\/j.clinthera.2008.06.005.","journal-title":"Clin Ther"},{"issue":"6","key":"1050_CR121","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/14656566.2024.2349791","volume":"25","author":"L Pellesi","year":"2024","unstructured":"Pellesi L, Do TP, Hougaard A. Pharmacological management of migraine: current strategies and future directions. Expert Opin Pharmacother. 2024;25(6):673\u201383. https:\/\/doi.org\/10.1080\/14656566.2024.2349791.","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"1050_CR122","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.26355\/eurrev_202005_21365","volume":"24","author":"XY Cui","year":"2020","unstructured":"Cui XY, Sun SM, Liu J, Wu QY, Zhang JF, Li X. The efficacy and safety of valproate medications for migraine in adults: a meta-analysis. Eur Rev Med Pharmacol Sci. 2020;24(10):5734\u201341. https:\/\/doi.org\/10.26355\/eurrev_202005_21365.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"1050_CR123","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1055\/s-0030-1248289","volume":"118","author":"M Sch\u00fctt","year":"2010","unstructured":"Sch\u00fctt M, Brinkhoff J, Drenckhan M, Lehnert H, Sommer C. Weight reducing and metabolic effects of topiramate in patients with migraine--an observational study. Exp Clin Endocrinol Diabetes. 2010;118(7):449\u201352. https:\/\/doi.org\/10.1055\/s-0030-1248289.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9","key":"1050_CR124","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1007\/s12325-023-02586-y","volume":"40","author":"NZ Pearl","year":"2023","unstructured":"Pearl NZ, Babin CP, Catalano NT, et al. Narrative review of topiramate: clinical uses and pharmacological considerations. Adv Ther. 2023;40(9):3626\u201338. https:\/\/doi.org\/10.1007\/s12325-023-02586-y.","journal-title":"Adv Ther"},{"issue":"7","key":"1050_CR125","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1089\/chi.2025.0007","volume":"21","author":"CE Batt","year":"2025","unstructured":"Batt CE, Puccio OC, Kelsey MM, Boles RE, Moore JM. Real-world use of phentermine and topiramate for adolescent obesity: retrospective effectiveness and safety analysis. Child Obes. 2025;21(7):580\u20138. https:\/\/doi.org\/10.1089\/chi.2025.0007.","journal-title":"Child Obes"},{"key":"1050_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.588016","volume":"12","author":"C Sari","year":"2021","unstructured":"Sari C, Seip RL, Umashanker D. Case report: off label utilization of topiramate and metformin in patients with BMI \u226550\u00a0kg\/m2 prior to bariatric surgery. Front Endocrinol (Lausanne). 2021;12:588016. https:\/\/doi.org\/10.3389\/fendo.2021.588016.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1050_CR127","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.eplepsyres.2014.01.021","volume":"108","author":"R Castilla-Puentes","year":"2014","unstructured":"Castilla-Puentes R, Ford L, Manera L, Kwarta RF Jr, Ascher S, Li Q. Topiramate monotherapy use in women with and without epilepsy: pregnancy and neonatal outcomes. Epilepsy Res. 2014;108(4):717\u201324. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.01.021.","journal-title":"Epilepsy Res"},{"issue":"1","key":"1050_CR128","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10194-024-01753-y","volume":"25","author":"R Oliveira","year":"2024","unstructured":"Oliveira R, Gil-Gouveia R, Puledda F. CGRP-targeted medication in chronic migraine - systematic review. J Headache Pain. 2024;25(1):51. https:\/\/doi.org\/10.1186\/s10194-024-01753-y.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR129","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s10194-025-02256-0","volume":"27","author":"CL Hoehne","year":"2026","unstructured":"Hoehne CL, Overeem LH, Sanchez-Del-Rio M, Deligianni C, Gil-Gouveia R, Versijpt J, et al. Decoding the long-term safety of anti-CGRP (receptor) mAbs: a meta-analysis and systematic review. J Headache Pain. 2026;27(1):10. https:\/\/doi.org\/10.1186\/s10194-025-02256-0.","journal-title":"J Headache Pain"},{"issue":"2","key":"1050_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.217","volume":"4","author":"B Baker","year":"2021","unstructured":"Baker B, Schaeffler B, Hirman J, Hompesch M, Pederson S, Smith J. Tolerability of eptinezumab in overweight, obese or type\u00a01 diabetes patients. Endocrinol Diabetes Metab. 2021;4(2):e00217. https:\/\/doi.org\/10.1002\/edm2.217.","journal-title":"Endocrinol Diabetes Metab"},{"issue":"12","key":"1050_CR131","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241299753","volume":"44","author":"BL Peterlin","year":"2024","unstructured":"Peterlin BL, Bond DS, Ailani J, et al. Weight loss with atogepant during the preventive treatment of migraine: a pooled analysis. Cephalalgia. 2024;44(12):3331024241299753. https:\/\/doi.org\/10.1177\/03331024241299753.","journal-title":"Cephalalgia"},{"issue":"13","key":"1050_CR132","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1177\/03331024221111526","volume":"42","author":"LF Iannone","year":"2022","unstructured":"Iannone LF, De Cesaris F, Ferrari A, Benemei S, Fattori D, Chiarugi A. Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine. Cephalalgia. 2022;42(13):1323\u201330. https:\/\/doi.org\/10.1177\/03331024221111526.","journal-title":"Cephalalgia"},{"issue":"1","key":"1050_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-01979-4","volume":"26","author":"Y He","year":"2025","unstructured":"He Y, Xu B, Zhang M, et al. Advances in GLP-1 receptor agonists for pain treatment and their future potential. J Headache Pain. 2025;26(1):46. https:\/\/doi.org\/10.1186\/s10194-025-01979-4.","journal-title":"J Headache Pain"},{"issue":"10","key":"1050_CR134","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/head.14991","volume":"65","author":"S Braca","year":"2025","unstructured":"Braca S, Russo CV, Stornaiuolo A, et al. Effectiveness and tolerability of liraglutide as add-on treatment in patients with obesity and high-frequency or chronic migraine: a prospective pilot study. Headache. 2025;65(10):1831\u20138. https:\/\/doi.org\/10.1111\/head.14991.","journal-title":"Headache"},{"issue":"6","key":"1050_CR135","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s13760-025-02894-w","volume":"125","author":"M Gultekin","year":"2025","unstructured":"Gultekin M, Davran F, Yuksel N, Beyazcicek O, Demir S. Assessment of serum glucagon-like peptide-1 and dipeptidyl peptidase-4 levels in patients with migraine. Acta Neurol Belg. 2025;125(6):1613\u201320. https:\/\/doi.org\/10.1007\/s13760-025-02894-w.","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"1050_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01925-w","volume":"25","author":"L Pellesi","year":"2024","unstructured":"Pellesi L, Garcia-Azorin D, Rubio-Beltr\u00e1n E, et al. Combining treatments for migraine prophylaxis: the state-of-the-art. J Headache Pain. 2024;25(1):214. https:\/\/doi.org\/10.1186\/s10194-024-01925-w.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010145","volume":"12","author":"JJ Gorgojo-Mart\u00ednez","year":"2023","unstructured":"Gorgojo-Mart\u00ednez JJ, Mezquita-Raya P, Carretero-G\u00f3mez J, et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2023;12(1):145. https:\/\/doi.org\/10.3390\/jcm12010145.","journal-title":"J Clin Med"},{"issue":"1","key":"1050_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-026-03494-y","volume":"26","author":"V Mutlu","year":"2026","unstructured":"Mutlu V, Karac\u0131 R, Y\u00fcksek MA, et al. Effect of bariatric surgery on headache frequency, duration and severity. BMC Surg. 2026;26(1):174. https:\/\/doi.org\/10.1186\/s12893-026-03494-y.","journal-title":"BMC Surg"},{"issue":"11","key":"1050_CR139","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.97294","volume":"17","author":"M Mahran","year":"2025","unstructured":"Mahran M, Al-Asadi O, Sobh R, Salloum D, Aljaafreh A. Effect of bariatric surgery on migraine headache: a systematic review and meta-analysis. Cureus. 2025;17(11):e97294. https:\/\/doi.org\/10.7759\/cureus.97294.","journal-title":"Cureus"},{"issue":"11","key":"1050_CR140","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1007\/s11695-022-06218-2","volume":"32","author":"HH Etefagh","year":"2022","unstructured":"Etefagh HH, Shahmiri SS, Melali H, et al. Bariatric surgery in migraine patients: CGRP level and weight loss. Obes Surg. 2022;32(11):3635\u201340. https:\/\/doi.org\/10.1007\/s11695-022-06218-2.","journal-title":"Obes Surg"},{"issue":"3","key":"1050_CR141","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s11695-019-04290-9","volume":"30","author":"JT Dang","year":"2020","unstructured":"Dang JT, Lee JKH, Kung JY, Switzer NJ, Karmali S, Birch DW. The effect of bariatric surgery on migraines: a systematic review and meta-analysis. Obes Surg. 2020;30(3):1061\u20137. https:\/\/doi.org\/10.1007\/s11695-019-04290-9.","journal-title":"Obes Surg"},{"issue":"1","key":"1050_CR142","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s10194-023-01666-2","volume":"24","author":"P Martelletti","year":"2023","unstructured":"Martelletti P, Leonardi M, Ashina M, et al. Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030. J Headache Pain. 2023;24(1):140. https:\/\/doi.org\/10.1186\/s10194-023-01666-2.","journal-title":"J Headache Pain"},{"issue":"1","key":"1050_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-026-02348-5","volume":"27","author":"P Martelletti","year":"2026","unstructured":"Martelletti P, de Oliveira AB, Dhamija RK, et al. Migraine, headache disorders, and brain health: aligning advocacy with the UN Sustainable Development Goals. J Headache Pain. 2026;27(1):94. https:\/\/doi.org\/10.1186\/s10194-026-02348-5.","journal-title":"J Headache Pain"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-01050-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:01:53Z","timestamp":1791597713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-01050-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":143,"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-01050-7","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"3 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Marta Waliszewska-Pros\u00f3\u0142 is a member of the Editorial Board of\n                      The Journal of Headache and Pain\n                      and an Advisory Board member of\n                      Neurology and Therapy\n                      and was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions. Bianca Raffaelli is a member of the Editorial Board of\n                      The Journal of Headache and Pain\n                      n and\n                      Cephalalgia\n                      ; reports personal fees from AbbVie, Lundbeck, Novartis, Organon, and Teva for participating in advisory boards and\/or speaker activities, as well as research funding from Lundbeck, Novartis, Else Kr\u00f6ner-Fresenius-Stiftung, German Research Foundation and German Migraine and Headache Society. Lanfranco Pellesi is a member of the Editorial Board of\n                      The Journal of Headache and Pain\n                      . Alberto Raggi is a member of the Editorial Board of\n                      The Journal of Headache and Pain\n                      . Dilara Onan is a member of the Editorial Board of\n                      The Journal of Headache and Pain\n                      . Karol Marschollek declares no conflict of interest. Danilo Antonio Montisano declares no conflict of interest. Claudio Tana is a member of the Editorial Board of\n                      The Journal of Headache and Pain\n                      and an Editor of the Primary Care Section of\n                      Annals of Medicine\n                      . Paolo Martelletti is the Editor-in-Chief of\n                      The Journal of Headache and Pain\n                      and of\n                      SN Comprehensive Clinical Medicine\n                      , is an Editorial Board member of\n                      Neurology and Therapy\n                      , and was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}